DrugDashboards

Market view

hydromorphone hydrochloride · Suppository

2 marketed package NDCs · 2 active manufacturers

Most dispensed: 16 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle · 12 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle · 8 mg · Tablet, Extended Release · #100 tablet, extended releases/bottle · 4 mg · Tablet · #100 tablets/bottle, plastic

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

What changed in the last 90 days

Every detected change for hydromorphone hydrochloride, newest first — price moves, shortages, recalls, and manufacturers entering or leaving. Detected by comparing each day’s federal data against the day before.

Same drug class

Other molecules FDA puts in Opioid Agonist, with whether each is in shortage right now. Same class is not the same drug — substitution is a clinical decision, and this is a supply picture, not a recommendation.

Common questions

Is Hydromorphone hydrochloride in shortage right now?
Yes. FDA currently lists Hydromorphone hydrochloride in shortage. This page is rebuilt every morning from FDA's shortage database.
Who makes Hydromorphone hydrochloride?
29 companies have marketed Hydromorphone hydrochloride in the last 30 days, according to the FDA NDC Directory. Every manufacturer and package is listed on this page.
What does Hydromorphone hydrochloride cost?
The typical pharmacy pays about $2.57 per unit, based on the most recent CMS NADAC survey of actual acquisition costs. That is what the pharmacy pays for the drug itself — not the cash price, and not what an insurer is billed.

Shortage reports for this molecule

  • Planned discontinuationHydromorphone Hydrochloride, Suppository, 3 mg (NDC 0574-7224-06)Jul 23, 2026

All marketed products

Expand a strength to see its dosage forms, then package sizes, then each manufacturer and NDC. Click an NDC for its full detail page.